| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |